Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face socio-economic or domestic challenges that can prevent clinical trial participation. These trials typically exceed planned recruitment timelines by years, and previous programs for this sponsor were cancelled due to low enrollment. To mitigate these known study risks, PRA commissioned our Site Engagement team early in the study-planning phase to help sites develop customized recruitment initiatives to strictly maintain enrollment timelines.
We’ve contributed to the successful approval of eight marketed cardio-metabolic drugs.
We work hand-in-hand with our sponsors to develop strategic, flexible approaches that leverage Clinical Informatics, state-of-the-art technologies,…
Data Monitoring Committee Unit
Due to increasing regulatory requirements, the need for quality study and patient safety data is critical as we work together to bring our clients’…